Institutional investors purchased a net $485.3 thousand shares of ABMD during the quarter ended September 2016 and now own 90.53% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GENEVA CAPITAL MANAGEMENT LLC Bought 22.1 Thousand shares of Abiomed Inc
THE BANK OF NEW YORK MELLON CORP... Bought 19.6 Thousand shares of Abiomed Inc